Application 065454
- Type
- ANDA
- Sponsor
- CHARTWELL LIFE SCI
Application Products#
Product, Drug, Ingredient table| Product | Drug | Ingredient | Form | Strength | Reference drug | Reference standard |
|---|
| 001 | DOXYCYCLINE | DOXYCYCLINE | FOR SUSPENSION;ORAL | EQ 25MG BASE/5ML | No | No |
NDC Listings For This Application#
NDC, Name, Nonproprietary name table| NDC | Name | Nonproprietary name | Labeler | Marketing category | Status |
|---|
| 62135-417 | Doxycycline | Doxycycline | Chartwell RX LLC | ANDA | Current |
| 62135-417 | Doxycycline | Doxycycline | Chartwell RX LLC | ANDA | Current |
| 62135-417 | doxycycline | doxycycline | Chartwell RX LLC | ANDA | Current |
| 62135-417 | doxycycline | doxycycline | Chartwell RX LLC | ANDA | Current |
| 62135-417 | doxycycline | doxycycline | Chartwell RX LLC | ANDA | Current |
| 62135-417 | doxycycline | doxycycline | Chartwell RX LLC | ANDA | Current |
| 67405-475 | Doxycycline | DOXYCYCLINE | Harris Pharmaceutical, Inc | ANDA | Current |
| 68999-417 | doxycycline | doxycycline | Chartwell Governmental & Specialty RX, LLC | ANDA | Current |
| 68999-417 | doxycycline | doxycycline | Chartwell Governmental & Specialty RX, LLC | ANDA | Current |
| 68999-417 | doxycycline | doxycycline | Chartwell Governmental & Specialty RX, LLC | ANDA | Current |
| 69097-228 | Doxycycline | DOXYCYCLINE | CIPLA USA, Inc | ANDA | Current |
Documents#
Document, Submission type, Date table| Document | Submission type | Date |
|---|
| 39426 | ORIG | 2008-07-22 |
| 30663 | ORIG | 2008-07-17 |